Skip to main content
logo
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
9.71
+0.33 (3.52%)
At close: Feb 26, 2026, 4:00 PM EST
8.38
-1.33 (-13.70%)
After-hours: Feb 26, 2026, 7:32 PM EST

Ginkgo Bioworks Holdings Revenue

In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. Ginkgo Bioworks Holdings had revenue of $33.40M in the quarter ending December 31, 2025, a decrease of -23.84%.

Revenue (ttm)
$170.16M
Revenue Growth
-25.06%
P/S Ratio
3.06
Revenue / Employee
$216,554
Employees
834
Market Cap
551.88M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals216.11M
CorMedix214.30M
Zevra Therapeutics84.39M
Fulcrum Therapeutics80.00M
ADC Therapeutics75.21M
Altimmune20.00K
Revenue Rankings

DNA News

More News